All of 23andMe's independent directors resigned from its board this week, a rare move that marks the latest challenge for the genetic-testing company.The resignations follow drawn-out negotiations with 23andMe CEO and co-founder Anne Wojcicki, who wants to take the company private.
23andMe, which went public in 2021, has struggled to find a profitable business model since. The company reported a net loss of $667 million for its last fiscal year, more than double the loss of $312 million for the year prior.Shares for 23andMe have also plummeted — with the company's stock closing at 33 cents Thursday, down more than 97% since its 2021 stock market debut, according to FactSet.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
23andMe board resigns in feud over CEO Anne Wojcicki's plan to take company privateThe board resignations followed CEO Anne Wojcicki’s latest proposal to take the company private.
Source: nypost - 🏆 91. / 67 Read more »
23andMe directors resign as the CEO of the genetic-testing company seeks to take it privateAll of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the genetic-testing company.
Source: ksatnews - 🏆 442. / 53 Read more »
23andMe directors resign as the CEO of the genetic-testing company seeks to take it privateAll of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the genetic-testing company. The resignations follow drawn-out negotiations with 23andMe CEO and co-founder Anne Wojcicki who wants to take the company private.
Source: AP - 🏆 728. / 51 Read more »
23andMe directors resign as the CEO of the genetic-testing company seeks to take it privateAll of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the genetic-testing company.
Source: wjxt4 - 🏆 246. / 63 Read more »